(3R,4S,5S,6R)-3,4,5-Trihydroxy-6-((((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl (8aR,10S,12bR,14bS)-10-(((4S,5S)-3-(((5S,6S)-3,5-dihydroxy-6-methyl-4-(((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate

Catalog No.: 
ACFOWR042
CAS No.: 
140360-29-8
Molecular Formula: 
C59H96O27
Molecular Weight: 
1237.39
(3R,4S,5S,6R)-3,4,5-Trihydroxy-6-((((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl (8aR,10S,12bR,14bS)-10-(((4S,5S)-3-(((5S,6S)-3,5-dihydroxy-6-methyl-4-(((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg99%$89.00In stockInquiry
50mg99%$157.00In stockInquiry
100mg99%$283.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4S,5S,6R)-3,4,5-Trihydroxy-6-((((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl (8aR,10S,12bR,14bS)-10-(((4S,5S)-3-(((5S,6S)-3,5-dihydroxy-6-methyl-4-(((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate
IUPAC Name(3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl (8aR,10S,12bR,14bS)-10-(((4S,5S)-3-(((5S,6S)-3,5-dihydroxy-6-methyl-4-(((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylate
MDL No.-
Molecular FormulaC59H96O27
Molecular Weight1237.39
SMILESC[C@@H]1OC(OC2C(O[C@H]3CCC4(C)[C@@H](CCC5(C)[C@@H]4CC=C4[C@@H]6CC(C)(C)CCC6(C(=O)OC6O[C@H](COC7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O)CCC45C)C3(C)CO)OC[C@H](O)[C@@H]2O)C(O)C(OC2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O
InChI KeyVUEGHZSQVJADCO-BWWGMJTESA-N
SynonymQ27271506 | Macranthoidin A | CCG-270663 | Olean-12-en-28-oic acid, 3-[(O-beta-D-glucopyranosyl-(1-->3)-O-6-deoxy-alpha-L-mannopyranosyl-(1-->2)-alpha-L-arabinopyranosyl)oxy]-23-hydroxy-, 6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl ester, (3beta,4alph
CAS No.140360-29-8
PubChem CID14564503

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFOWR042 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFOWR042 route product structure diagram
    ACFOWR042140360-29-8In Stock
Inquiry

2. ACFOWR042 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFOWR042 route product structure diagram
    ACFOWR042140360-29-8In Stock
Inquiry

3. ACFOWR042 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFOWR042 route product structure diagram
    ACFOWR042140360-29-8In Stock
Inquiry

Comments (0)